MPE Masterclass 2025 | Agenda

Plenary Session 1
Myeloma and AL amyloidosis treatment updates

Dr. Paweł Steckiewicz
Consultant Haematologist, Deputy Head of Clinical Department of Hematology and Bone Marrow Transplantation, ŚCO

Plenary Session 2
Sequencing of myeloma treatment

Prof. Dominik Dytfeld
Associate Professor, Department of Hematology and Bone Marrow Transplantation, Medical University of Poznań and President of the Polish Myeloma Consortium

Plenary Session 3
Early diagnosis screening

Prof. Irit Avivi
Director Hematology department TASMC at Tel Aviv Sourasky Medical Center

Breakout Sessions
1. Generating patient evidence for national patient groups

Eilidh Duncan
Head of Patient Research, MPE
Martine Elias
Chief Executive Officer, Myeloma Canada

2. Collaboration with pharma – Working well with industry

TBC

Plenary Session 4
Use of AI in patient care and treatment

Adam Radziszewski
Lead Applied Scientist at Infermedica
Solène Clavreul
Head of Medical Education and Scientific Engagement, MPE

Poster presentations and info stands 

Member programmes and success stories and MPE projects 

Plenary Session 5
Care for carers

Tone Hansen
Clinical Psychologist, Norway

Prabneet Parmar
Support Group Co-ordinator, MUK

Denise Young
Peer Services Coordinator, MUK

Magdelina Pietras
Myeloma patient carer

Plenary Session 6
EU Health Technology Assessment

Roisin Adams
Head of HTA Strategy and External Engagement for the NCPE and Chair of the EU Member State HTA Coordination group
Monica Racoviță
Access and Policy Manager, MPE

Panel Discussion 1
How to work well with
1. National government
2. Health Ministry

TBC

Dominik Romiński
Kierunek Zdrowie, MPE Member